News
Cycle Pharma enters exclusive US commercialization agreement with Handa for Phyrago to treat two types of leukaemia, Ph+ CML & Ph+ ALL: Cambridge, UK Wednesday, July 23, 2025, 16: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback